VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $660,841 | +73.5% | 116,963 | +26.2% | 0.00% | – |
| Q1 2024 | $380,886 | -2.6% | 92,673 | 0.0% | 0.00% | – |
| Q4 2023 | $391,080 | -9.4% | 92,673 | -7.2% | 0.00% | – |
| Q3 2023 | $431,451 | -13.1% | 99,873 | +32.6% | 0.00% | – |
| Q2 2023 | $496,510 | +15.0% | 75,343 | +18.5% | 0.00% | – |
| Q1 2023 | $431,864 | -18.8% | 63,603 | -11.6% | 0.00% | – |
| Q4 2022 | $531,747 | -25.1% | 71,955 | +0.1% | 0.00% | – |
| Q3 2022 | $710,000 | -9.3% | 71,901 | +0.1% | 0.00% | – |
| Q2 2022 | $783,000 | -59.7% | 71,817 | -58.2% | 0.00% | -100.0% |
| Q1 2022 | $1,941,000 | +73.5% | 171,627 | +140.6% | 0.00% | – |
| Q4 2021 | $1,119,000 | -46.1% | 71,347 | -41.1% | 0.00% | -100.0% |
| Q3 2021 | $2,077,000 | +31.0% | 121,203 | +64.4% | 0.00% | 0.0% |
| Q2 2021 | $1,586,000 | +43.3% | 73,723 | 0.0% | 0.00% | – |
| Q1 2021 | $1,107,000 | +14.5% | 73,723 | +0.2% | 0.00% | – |
| Q4 2020 | $967,000 | +36.0% | 73,583 | 0.0% | 0.00% | – |
| Q3 2020 | $711,000 | -15.4% | 73,583 | +0.3% | 0.00% | – |
| Q2 2020 | $840,000 | +7.6% | 73,393 | -2.7% | 0.00% | -100.0% |
| Q1 2020 | $781,000 | -36.8% | 75,403 | +0.1% | 0.00% | 0.0% |
| Q4 2019 | $1,236,000 | +24.2% | 75,303 | +0.5% | 0.00% | 0.0% |
| Q3 2019 | $995,000 | -18.7% | 74,953 | -13.8% | 0.00% | 0.0% |
| Q2 2019 | $1,224,000 | -56.4% | 86,903 | -43.1% | 0.00% | -50.0% |
| Q1 2019 | $2,810,000 | -29.6% | 152,713 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $3,990,000 | +8.2% | 152,713 | -5.0% | 0.00% | +50.0% |
| Q3 2018 | $3,689,000 | +20.5% | 160,753 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $3,062,000 | +65.5% | 160,753 | +46.5% | 0.00% | +100.0% |
| Q1 2018 | $1,850,000 | +10.9% | 109,763 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $1,668,000 | -18.5% | 109,763 | -4.0% | 0.00% | -50.0% |
| Q3 2017 | $2,047,000 | +86.6% | 114,363 | +69.9% | 0.00% | +100.0% |
| Q2 2017 | $1,097,000 | +62.5% | 67,303 | +39.6% | 0.00% | 0.0% |
| Q1 2017 | $675,000 | -83.0% | 48,228 | -80.6% | 0.00% | -66.7% |
| Q4 2016 | $3,972,000 | -11.8% | 249,028 | -8.0% | 0.00% | -25.0% |
| Q3 2016 | $4,504,000 | +219.2% | 270,678 | +114.7% | 0.00% | +300.0% |
| Q2 2016 | $1,411,000 | +245.8% | 126,078 | +158.2% | 0.00% | – |
| Q1 2016 | $408,000 | -21.1% | 48,828 | -12.1% | 0.00% | – |
| Q4 2015 | $517,000 | -17.4% | 55,528 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $626,000 | -11.2% | 55,528 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $705,000 | +36.6% | 55,528 | 0.0% | 0.00% | – |
| Q1 2015 | $516,000 | -35.1% | 55,528 | 0.0% | 0.00% | -100.0% |
| Q4 2014 | $795,000 | +38.0% | 55,528 | 0.0% | 0.00% | – |
| Q3 2014 | $576,000 | -35.9% | 55,528 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $898,000 | -21.4% | 55,528 | -21.1% | 0.00% | 0.0% |
| Q1 2014 | $1,143,000 | +113.2% | 70,341 | +62.7% | 0.00% | – |
| Q4 2013 | $536,000 | +13.1% | 43,228 | 0.0% | 0.00% | – |
| Q3 2013 | $474,000 | -33.9% | 43,228 | -51.3% | 0.00% | -100.0% |
| Q2 2013 | $717,000 | – | 88,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 332,863 | $2,260,140 | 1.49% |
| Krensavage Asset Management, LLC | 361,560 | $2,455 | 0.75% |
| Sio Capital Management, LLC | 123,797 | $840,582 | 0.42% |
| SummerHaven Investment Management, LLC | 71,447 | $485,125 | 0.28% |
| Palo Alto Investors LP | 482,697 | $3,277,513 | 0.27% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,059,240 | 0.17% |
| Virtus ETF Advisers LLC | 42,540 | $288,847 | 0.16% |
| CAXTON ASSOCIATES LP | 153,384 | $1,041,477 | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 688,337 | $4,673,808 | 0.12% |
| TANG CAPITAL MANAGEMENT LLC | 100,000 | $679,000 | 0.10% |